Quidel Corp.: FDA filings under this applicant name
FDA lists 128 510(k) clearances under 2 spellings of the applicant name “Quidel Corp.” (first 1983, latest 2024), plus 1 PMA and 2 De Novo decisions, across 37 product codes in 5 review panels. Median 510(k) review time under this name: 72 days. Since 2017 the median was 108 days, against 128 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under QuidelOrtho, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 2 | 64 |
| 2013 | 11 | 78 |
| 2014 | 6 | 82 |
| 2015 | 2 | 100 |
| 2016 | 5 | 88 |
| 2017 | 7 | 128 |
| 2018 | 4 | 88 |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 1 | 204 |
| 2022 | 0 | — |
| 2023 | 4 | 30 |
| 2024 | 1 | 276 |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Quidel Corp. took a median 108 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 128 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JHI | Visual, Pregnancy Hcg, Prescription Use | 20 | 20 |
| DHB | System, Test, Radioallergosorbent (Rast) Immunological | 9 | 9 |
| LCX | Kit, Test, Pregnancy, Hcg, Over The Counter | 9 | 9 |
| GTZ | Antisera, All Groups, Streptococcus Spp. | 8 | 8 |
| PSZ | Devices Detecting Influenza A, B, And C Virus Antigens | 8 | 8 |
| LYR | Helicobacter Pylori | 6 | 6 |
| GTY | Antigens, All Groups, Streptococcus Spp. | 5 | 5 |
| JJX | Single (Specified) Analyte Controls (Assayed And Unassayed) | 5 | 5 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | 5 | 5 |
| GQG | Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus | 4 | 4 |
Plus 27 more product codes.
Review panels
- Microbiology (75)
- Clinical Chemistry (41)
- Immunology (13)
- Pathology (1)
- Radiology (1)
Most recent Quidel Corp. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K231795 | QuickVue COVID-19 Test | QYT | 2024-03-22 | 276 |
| K232286 | Savanna HSV 1+2/VZV Assay, Savanna HSV 1+2/VZV Control Set, Savanna Instrument | PGI | 2023-12-20 | 141 |
| K233688 | Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab Set | QVF | 2023-12-13 | 26 |
| K230349 | Lyra RSV+hMPV Assay | OEM | 2023-03-10 | 29 |
| K230236 | Lyra Influenza A+B Assay | OZE | 2023-03-03 | 32 |
| K211342 | Sofia 2 Campylobacter FIA | LQP | 2021-11-23 | 204 |
| K173496 | Sofia 2 Lyme FIA, Sofia Lyme Control Set | LSR | 2018-08-30 | 290 |
| K181029 | Solana Bordetella Complete Assay | OZZ | 2018-07-15 | 88 |
| K173691 | Sofia Lyme FIA, Sofia 2 analyzer, Sofia 2 Installation Pack | LSR | 2018-02-28 | 89 |
| K180288 | QuickVue Influenza A+B | PSZ | 2018-02-13 | 12 |
118 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN220039 | De Novo | Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings | 2023-03-08 |
| DEN140005 | De Novo | Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | 2014-04-16 |
| P990039 | PMA | QUS-2 (TM) CALCANEAL ULTRASONOMETER | 2000-08-01 |
Recalls
15 product recalls in 14 recall events; 6 initiated in the last five years. Most recent: 2026-04-06.
2 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 2 initiated in the last five years. Most often: Mckesson Medical-Surgical Inc. Corporate Office (1), Ortho-Clinical Diagnostics, Inc. (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Quidel Corp. is the lead sponsor of 8 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT03238274: Sofia 2 Lyme FIA Whole Blood Clinical Study (Completed, started 2017-06-06)
- NCT03417869: QuickVue Influenza A + B Test Field Study (Completed, started 2017-02-16)
- NCT02566447: "Solana™ Trichomonas Assay Field Study" (Completed, started 2015-10-15)
- NCT01803113: Sofia hCG FIA Field Study (Completed, started 2013-01)
- NCT01734668: Sofia RSV FIA Field Study (Completed, started 2012-03)
Parent company SEC filings
QuidelOrtho Corp (QDEL): EDGAR filings, CIK 1906324. Caduvo groups Quidel Corp. under QuidelOrtho; the parent's SEC registrant is entered by hand for the group, not matched by name.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Quidel Corp. (a text match, not an official crosswalk):
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Quidel Corp. (94)
- Quidel Corporation (37)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Quidel Cardiovascular, Inc. (2 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Quidel Corp.?
FDA lists 128 510(k) clearances under 2 spellings of the applicant name “Quidel Corp.” (first 1983, latest 2024), plus 1 PMA and 2 De Novo decisions, across 37 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Quidel Corp.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Quidel Corp. is 72 days. Since 2017: 108 days, versus 128 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Quidel Corp.?
The most frequent FDA product codes under this applicant name are JHI (Visual, Pregnancy Hcg, Prescription Use, 20); DHB (System, Test, Radioallergosorbent (Rast) Immunological, 9); LCX (Kit, Test, Pregnancy, Hcg, Over The Counter, 9).
Next steps
- See all 128 Quidel Corp. clearances with predicates and recalls
- Run predicate analysis for product code JHI, Quidel Corp.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.